Výsledky vyhledávání - "Dirk Roelfs Meyer"

Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon

Autor: Peter Reimer, Marianne Brodmann, Michael R. Jaff, Illumenate Eu Rct Investigators, Karsten Krüger, Dirk-Roelfs Meyer, Henrik Schroeder, Martin Werner, Juan F. Granada

Publikováno v: JACC: Cardiovascular Interventions. 11:2357-2364

Objectives The aim of this study was to assess the safety and effectiveness of a next-generation low-dose drug-coated balloon (DCB) designed to optimize the amount of drug transferred into the vessel wall and to maximize the amount of time the drug r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0186b3cff947b846a93476cb6b89af01
https://doi.org/10.1016/j.jcin.2018.08.034

Zobrazit plný text záznamu

Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions

Autor: Dirk-Roelfs Meyer, Klaus Brechtel, Elias Noory, Ulrich Beschorner, Thomas Albrecht, Thomas Zeller

Publikováno v: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 27(5)

Purpose: To evaluate the safety and efficacy of the novel SELUTION sustained-limus-release (SLR) drug-eluting balloon (DEB) in the treatment of femoropopliteal lesions. Materials and Methods: Between October 2016 and May 2017, 50 subjects (mean age 6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7e477f80feb8f88191e4e5fc17c8fc2
https://pubmed.ncbi.nlm.nih.gov/32748683

Zobrazit plný text záznamu

Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease

Autor: Peter Reimer, Marianne Brodmann, Michael R. Jaff, Karsten Krüger, Henrik Schroeder, Dirk-Roelfs Meyer, Martin Werner

Publikováno v: Circulation. 135:2227-2236

Background: Numerous studies have reported favorable outcomes using drug-coated balloons (DCBs) for treatment of symptomatic peripheral artery disease of the superficial femoral and popliteal arteries. However, the treatment effect compared with an u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f0e0b1b935906249016f8855b4775baf
https://doi.org/10.1161/circulationaha.116.026493

Zobrazit plný text záznamu

Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results

Autor: Marianne, Brodmann, Martin, Werner, Dirk-Roelfs, Meyer, Peter, Reimer, Karsten, Krüger, Juan F, Granada, Michael R, Jaff, Henrik, Schroeder

Publikováno v: JACC. Cardiovascular interventions. 11(23)

The aim of this study was to assess the safety and effectiveness of a next-generation low-dose drug-coated balloon (DCB) designed to optimize the amount of drug transferred into the vessel wall and to maximize the amount of time the drug resides in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1655cd33d4fde282b2e2b8c71e0cf9fe
https://pubmed.ncbi.nlm.nih.gov/30522664

Zobrazit plný text záznamu

Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound?

Autor: Thomas Albrecht, Dirk-Roelfs Meyer, Ilka Ott, Özlem Gögebakan, Catherine Roca, Stefan Müller-Hülsbeck, Matthias Waliszewski, Gunnar Tepe, Ines Gemeinhardt, Maciej Pech, Jörg Tautenhahn, Thomas Zeller, Zuhir Halloul, U. Redlich

Publikováno v: Cardiovascular and interventional radiology. 41(7)

The previously reported 6-month angiographic and 12-month clinical outcomes of the CONSEQUENT trial demonstrated the safety and efficacy of a novel paclitaxel–resveratrol-coated balloon for the treatment of lesions in the femoropopliteal segment. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1acbab7ed12f5755ef7a9e33915a5b
https://pubmed.ncbi.nlm.nih.gov/29589098

Zobrazit plný text záznamu

Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first-in-human study

Autor: Beata Lux, Ferdinand Ruecker, Henrik Schroeder, Stephan H. Duda, Marcello Martorana, Dirk-Roelfs Meyer

Publikováno v: Catheterization and Cardiovascular Interventions. 86:278-286

Objectives To assess the safety and effectiveness of the Stellarex™ drug-coated angioplasty balloon (DCB) to inhibit restenosis in the superficial femoral and/or popliteal artery. Background Treatment of peripheral arterial disease is challenged by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63b99814b0489b77e1e1bec3706f5ecb
https://doi.org/10.1002/ccd.25900

Zobrazit plný text záznamu

Correction to: Impact of Patient and Lesion Characteristics on Drug-Coated Balloon Angioplasty in the Femoropopliteal Artery: A Pooled Analysis of Four Randomized Controlled Multicenter Trials

Autor: Matthias Waliszewski, Thomas Albrecht, Antonia Ukrow, Thomas Zeller, Maren Kutschera, Ulrich Speck, Dirk-Roelfs Meyer, M. Werk, Gunnar Tepe

Publikováno v: CardioVascular and Interventional Radiology. 42:1055-1055

In their recently published pooled analysis of four drug-coated balloon (DCB) studies, which focused on the impact of patient and lesion characteristics on LLL at 6 months (Albrecht T et al. Cardiovasc Intervent Radiol. 2018 Dec 11. https://doi.org/1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::246b2ae822753356e3b4440e5311887a
https://doi.org/10.1007/s00270-019-02203-y

Zobrazit plný text záznamu

Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty

Autor: Ulrich Dietz, Holger Hartmann, Mohammed Nabil Ahmed, Giuseppe Biondi Zoccai, Beatrix Schnorr, Christian Lange, H. Stiepani, Dirk Roelfs Meyer, Enrique Lopez Hänninen, M. Werk, Thomas Albrecht, Götz Eschenbach, Andrea Behne

Publikováno v: Circulation: Cardiovascular Interventions. 5:831-840

Background— Peripheral percutaneous transluminal angioplasty is fraught with a substantial risk of restenosis and reintervention. A drug-eluting balloon (DEB) based on a novel coating was compared with uncoated balloons in patients undergoing femor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0f0fdb674869a8ca83d93f3d133c83b
https://doi.org/10.1161/circinterventions.112.971630

Zobrazit plný text záznamu

TCT-525 First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA

Autor: Thomas Albrecht, Ulrich Beschorner, Thomas Zeller, Klaus Brechtel, Dirk-Roelfs Meyer

Publikováno v: Journal of the American College of Cardiology. 72:B211

Most Drug Coated Balloons (DCB) typically transfer drugs with an excipient to the vessel wall during balloon expansion within minutes. By inventing a new technology sirolimus containing PLGA microspheres were attached to a balloon surface within a ph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::465114e61083d8ad2d073cd55633c624
https://doi.org/10.1016/j.jacc.2018.08.1706

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání